SCHEMBL21111282

SCHEMBL21111282

CN1C(=O)[C@@H](N(C(=O)O)C(C)(C)C)COc2ccc(C(=O)NN)cc21

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 19/20 0.41
USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21111285 1.00 RIPK1 (0.41) RIPK1USP30
SCHEMBL17312488 0.92 RIPK1 (0.41) RIPK1
SCHEMBL17312486 0.92 RIPK1 (0.41) RIPK1
SCHEMBL18409596 0.86 RIPK1 (0.41) RIPK1
SCHEMBL18409597 0.86 RIPK1 (0.41) RIPK1
SCHEMBL21111151 0.85 USP30 (0.42) RIPK1USP30
SCHEMBL21111150 0.85 USP30 (0.42) RIPK1USP30
SCHEMBL17312431 0.82 KIF11 (0.40) RIPK1
SCHEMBL17312429 0.82 KIF11 (0.40) RIPK1
SCHEMBL17312438 0.82 HPGD (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508484-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-07-10 EP disclosed